Skip to main content
Article thumbnail
Location of Repository


By Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini and Paolo Bonanni


In Puglia region 58% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 70 cases of cervicocarcinoma and 31 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (9,935 €/QALY)

Topics: HPV, Vaccination strategy, Screening, Puglia, Cost-effectiveness analysis, Public aspects of medicine, RA1-1270, Medicine, R, Medicine (General), R5-920
Publisher: SEEd Medical Publishers
Year: 2012
DOI identifier: 10.7175/fe.v13i2S.463
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • http://journals.edizioniseed.i... (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.